Amgen to Buy Human Heavy Chain Antibodies Biotech Teneobio

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
  • #26624
    Super Harley

    Amgen today announced it will acquire privately held,…



    Reads like a solid acquisition = the rats sound interesting


    Morgan Stanley downgraded Amgen (AMGN) to Equal Weight from Overweight with a price target of $251, down from $280.

    While the firm is not changing his near-term forecasts and thinks management continues to run the business successfully, the firm believes more work needs to be done to improve the growth outlook after the mid-decade loss of exclusivity of Prolia, XGEVA, and Evenity and sees better risk/reward elsewhere based on a broad review of the stocks the firm covers.

Viewing 3 posts - 1 through 3 (of 3 total)
  • You must be logged in to reply to this topic.